The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research groups cover every aspect ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

Giving radiotherapy in fewer treatments but at higher doses could work just as well as standard regimes, but be cheaper and more convenient for patients.

Professor Peter Garland CBE, who served as Chief Executive of the ICR from 1989 to 1999, passed away on 5 March. He also played an important role as the Chair of Cambridge Antibody Technology (CAT) ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

Tina Regan, 68, has been touched by cancer personally and has seen the devastating impact it has had on her immediate family. That is why she has pledged to leave a gift in her Will to fund our vital ...

The Terry Fox Run UK had its most successful year of fundraising ever in 2024, in no small part due to the generous support of multiple companies from far and wide. The grand total raised was £120,000 ...